Effect of transnasal insufflation on sleep disordered breathing in acute stroke

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000150943

Enrollment

Registered

2011-02-09

Start date

2010-02-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sleep disordered breathing (SDB) is frequent in acute stroke patients and is associated with early neurologic worsening and poor outcome. Although continuous positive airway pressure (CPAP) effectively treats SDB, compliance is low. The objective of the present study was to assess the tolerance and the efficacy of transnasal insufflation (TNI), a less intrusive method, to treat SDB in acute stroke patients.

Interventions

The objective of the present study is to assess the tolerance and the efficacy of transnasal insufflation to treat sleep apnoea in acute stroke patients. Trans-nasal insufflation is a less invasive method to treat apneas/hypopneas than CPAP. It delivers warm and humidified air at a continuous high flow rate (18 l/min) through an open nasal cannula. It is applied during the one night.

Study design

Allocation

Non-randomised trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

patients admitted for acute ischemic stroke

Exclusion criteria

Patients unable to consent due to the severity of the stroke are excluded

Outcome results